Latest News about Psychedelic Assisted Therapies
Recent news which mentions Psychedelic Assisted Therapies
JD Vance Considers Psychedelic Therapy For Vets: Insights From Joe Rogan Interview
November 01, 2024
Tickers
NEWS
From Benzinga
As Psilocybin Trials Face Delays, Compass Pathways (CMPS) Cuts Workforce To Conserve Cash
October 31, 2024
From Benzinga
From Benzinga
Eliza Dushku Pushes For Psychedelics Legalization In Massachusetts - A Personal Journey, A Public Cause
October 29, 2024
Tickers
NEWS
From Benzinga
Global Psychedelic Drugs Market Expected To Reach $10.2B By 2028 Amid Growing Mental Health Crises
October 28, 2024
From Benzinga
Psychedelic Drug DOI Pinpoints Anxiety Circuits Avoiding Hallucinogenic Effects, Study Finds
October 28, 2024
Tickers
NEWS
From Benzinga
Ireland's First Psychedelic Conference Explores Substances As Mental Health Treatment
October 25, 2024
From Benzinga
From Benzinga
How Psychedelic Experiences Affect Couples: New Study Looks Into It
October 17, 2024
Tickers
MDMA
From Benzinga
News Hampshire Lawmakers Reject Psychedelics Bill Citing Safety Concerns Though Support Continued Research
October 16, 2024
Tickers
NEWS
From Benzinga
Awakn Partners With University Of Nottingham For Preclinical Testing Of Psychoactive Therapy
October 15, 2024
From Benzinga
From Benzinga
Could Psilocybin Be A Game-Changer For Millions Battling Depression? New Study Says Yes
October 07, 2024
From Benzinga
Psychedelics 2.0: Companies Explore Safer, More Targeted Therapies
October 04, 2024
From Benzinga
Michigan Bill Could Legalize Psychedelic Mushrooms For PTSD Treatment
September 30, 2024
Tickers
NEWS
From Benzinga
Minnesota Moves Forward With Psilocybin Therapy Plan, Eyes Broader Psychedelic Reforms
September 26, 2024
Tickers
NEWS
From Benzinga
Sam Altman's Psychedelic Breakthrough: How The OpenAI Visionary Plans To Transform Mental Health Care With MDMA
September 25, 2024
From Benzinga
European Initiative Pushes For Psychedelic Therapy Reform To Address $669B Mental Health Problem: The Goal Is To Gather 1 Million Signatures
September 19, 2024
From Benzinga
Ultra-Low-Dose Ketamine May Offer Relief For Opioid Withdrawal, Study Finds
September 18, 2024
From Benzinga
From Benzinga
MDMA Therapy For PTSD Faces FDA Delay: Are There Other Ways Forward?
September 12, 2024
From Benzinga
Biden Administration Finalizes Rule To Expand Mental Health Care Access: How This Could Impact The Psychedelics Industry
September 10, 2024
Tickers
NEWS
From Benzinga
Incannex Secures $60M Financing To Drive Advances In Psychedelic And Cannabinoid Therapies
September 10, 2024
Tickers
IXHL
From Benzinga
Psyence Biomed Launches First Trial Site In Australia For Phase IIb Psilocybin Study In Palliative Care
September 09, 2024
From Benzinga
How Set And Setting Impact The Effects Of LSD, New Study Sheds Light
September 05, 2024
Tickers
NEWS
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.